IWII Wound Infection in Clinical Practice consensus document: 2022 update.

antimicrobial antimicrobial stewardship biofilm clinical guidance debridement infection wound wound care wound cleansing wound continuum wound dressing wound healing wound infection

Journal

Journal of wound care
ISSN: 0969-0700
Titre abrégé: J Wound Care
Pays: England
ID NLM: 9417080

Informations de publication

Date de publication:
01 Dec 2022
Historique:
entrez: 8 12 2022
pubmed: 9 12 2022
medline: 15 12 2022
Statut: ppublish

Résumé

Wound infection is a major challenge for clinicians globally, with accurate and timely identification of wound infection being critical to achieving clinical and cost-effective management, and promotion of healing. This paper presents an overview of the development of the International Wound Infection Institute (IWII)'s 2022 Wound Infection in Clinical Practice consensus document. The updated document summarises current evidence and provides multidisciplinary healthcare providers with effective guidance and support on terminology, paradigms related to biofilm, identification of wound infection, wound cleansing, debridement and antimicrobial stewardship. Integral to the update is revision of wound infection management strategies which are incorporated within the IWII's Wound Infection Continuum (IWII-WIC) and management plan. The aim of the 2022 IWII consensus document update was to provide an accessible and useful clinical resource in at least six languages, incorporating the latest evidence and current best practice for wound infection and prevention. Dissemination techniques for the consensus are discussed and highlighted.

Identifiants

pubmed: 36475844
doi: 10.12968/jowc.2022.31.Sup12.S10
doi:

Types de publication

Journal Article

Langues

eng

Pagination

S10-S21

Auteurs

Terry Swanson (T)

Wound Education Research Consultancy.

Karen Ousey (K)

Professor of Skin Integrity, Institute of Skin Integrity and Infection Prevention, University of Huddersfield, UK.
Adjunct Professor, School of Nursing, Queensland University of Technology, Australia.
Visiting Professor, Royal College of Surgeons Ireland, Dublin, Ireland.

Emily Haesler (E)

Adjunct Professor, Curtin Health Innovation Research Institute, Curtin University, Perth, Australia.
Adjunct Associate Professor, Australian Centre for Evidence Based Aged Care, La Trobe University, Melbourne, Australia.
Honorary Senior Lecturer, The Australian National University Medical School, Canberra, Australia.

Thomas Bjarnsholt (T)

Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.

Keryln Carville (K)

Professor of Primary Health Care, Silver Chain and Curtin Health Innovation Research Institute, Curtin University, Perth, Australia.

Patricia Idensohn (P)

Wound Nurse Specialist, Educator & Consultant in Private Practice, CliniCare, Ballito, South Africa.
Principal Lecturer and Co-Ordinator, School of Nursing, University of the Free State, South Africa.

Lindsay Kalan (L)

Medical Microbiology & Immunology, University of Wisconsin, US.

David H Keast (DH)

Parkwood Institute, St Joseph's Healthcare, London, Canada.

Donna Larsen (D)

Royal Perth Bentley Group, Perth, Australia.

Steven Percival (S)

Professor (Honorary), University of Liverpool, UK.
CEO and Director, Biofilm Centre, 5D Health Protection Group Ltd, Liverpool, UK.

Gregory Schultz (G)

Emeritus Professor of Obstetrics & Gynecology, University of Florida, US.

Geoff Sussman (G)

Associate Professor of Wound Care, Faculty of Medicine, Nursing and Health Science, Monash University, Australia.
Clinical Lecturer Medical Education, University of Melbourne, Australia.

Nicola Waters (N)

Senior Research Associate, Health, The Conference Board of Canada.
Adjunct Professor, University of British Columbia, Okanagan, Canada.

Dot Weir (D)

Clinician, Saratoga Hospital Center for Wound Healing and Hyperbaric Medicine, Saratoga Springs, New York, US.
Co-chair, Symposium on Advanced Wound Care, US.
Faculty, Wound Certification Prep Course, US.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH